About Ab&b Biotechnology
Ab&b Biotechnology is a company based in Taizhou (China) founded in 2015.. Ab&b Biotechnology has raised $92.76 million across 1 funding round from investors including Green Pine Capital Partners, Yingke Capital and Honghui Fund. Ab&b Biotechnology operates in a competitive market with competitors including Adaptive Biotechnologies, Moderna, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others.
- Headquarter Taizhou, China
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Ab&B Bio-Tech Co., Ltd. Js Class H
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$92.76 M (USD)
in 1 rounds
-
Latest Funding Round
$92.76 M (USD), Series C
Aug 04, 2021
-
Investors
Green Pine Capital Partners
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ab&b Biotechnology
Ab&b Biotechnology is a publicly listed company on the HKEX with ticker symbol 2627 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Ab&b Biotechnology
Ab&b Biotechnology has successfully raised a total of $92.76M through 1 strategic funding round. The most recent funding activity was a Series C round of $92.76 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $92.8M
-
First Round
First Round
(04 Aug 2021)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series C - Ab&b Biotechnology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ab&b Biotechnology
Ab&b Biotechnology has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Green Pine Capital Partners, Yingke Capital and Honghui Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early- and growth-stage investments are directed toward hard technology sectors.
|
Founded Year | Domain | Location | |
|
Healthcare startups are funded by HLC venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ab&b Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Abb Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ab&B Biotechnology Comparisons
Competitors of Ab&b Biotechnology
Ab&b Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptive Biotechnologies, Moderna, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ab&B Biotechnology
Frequently Asked Questions about Ab&b Biotechnology
When was Ab&b Biotechnology founded?
Ab&b Biotechnology was founded in 2015 and raised its 1st funding round 6 years after it was founded.
Where is Ab&b Biotechnology located?
Ab&b Biotechnology is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.
Is Ab&b Biotechnology a funded company?
Ab&b Biotechnology is a funded company, having raised a total of $92.76M across 1 funding round to date. The company's 1st funding round was a Series C of $92.76M, raised on Aug 04, 2021.
What does Ab&b Biotechnology do?
Founded in 2015 and based in Taizhou, China, the biotechnology company focuses on vaccine development within the healthcare sector. Proprietary technology is employed to create a quadrivalent subunit vaccine targeting four influenza virus strains. Operations center on research and production of influenza protections, with emphasis on efficacy against seasonal variants. The domain abbbio.com supports company information and outreach.
Who are the top competitors of Ab&b Biotechnology?
Ab&b Biotechnology's top competitors include Moderna, Adaptive Biotechnologies and Vaxcyte.
Is Ab&b Biotechnology publicly traded?
Yes, Ab&b Biotechnology is publicly traded on HKEX under the ticker symbol 2627.
Who are Ab&b Biotechnology's investors?
Ab&b Biotechnology has 4 investors. Key investors include Green Pine Capital Partners, Yingke Capital, Honghui Fund, and Guohai Innovation Capital Investment Management.
What is Ab&b Biotechnology's ticker symbol?
The ticker symbol of Ab&b Biotechnology is 2627 on HKEX.